Showing results (31-40 of 47) with videos related to
Sort By:
Pageof 5
Biochemical Pharmacology|March 3, 1992
Modulation of melphalan uptake in murine L5178Y lymphoblasts in vitro by changes in ionic environmentL Miller, A M Deffie, R Bose, et al.Journal of Medicinal Chemistry|February 1, 1979
Synthesis of steroidal nitrosoureas with antitumor activityH Y Lam, A Begleiter, G J Goldenberg, et al.Cancer Treatment Reports|October 1, 1987
Estrogen receptor-binding affinity and cytotoxic activity of three new estrogen-nitrosourea conjugates in human breast cancer cell lines in vitroH Y Lam, P K Ng, G J Goldenberg, et al.Cancer Research|August 1, 1987
Expression of the gene encoding a prolactin-inducible protein by human breast cancers in vivo: correlation with steroid receptor statusL C Murphy, M Lee-Wing, G J Goldenberg, et al.Cytogenetics and Cell Genetics|January 1, 1996
Allelic fusion of DNA topoisomerase II alpha and retinoic acid receptor alpha genes in adriamycin-resistant p388 murine leukemia revealed by fluorescence in situ hybridizationJ A Squire, J P McPherson, B G Beatty, et al.Cancer Research|December 15, 1988
Growth-promoting activity of desmopressin in murine leukemia cells treated in vitroS W Beenken, J K Batra, J M Gerrard, et al.Lancet (London, England)|September 24, 1977
Correlation between leucocyte-migration inhibition by breast-cancer antigens, mammographic findings, and other breast-cancer risk factorsL J Brandes, M K Kiernan, G Hardy, et al.Cancer Research|April 1, 1988
Characterization of L5178Y murine lymphoblasts resistant to quinone antitumor agentsA Begleiter, M K Leith, G McClarty, et al.Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|May 1, 1992
Multifactorial resistance to antineoplastic agents in drug-resistant P388 murine leukemia, Chinese hamster ovary, and human HeLa cells, with emphasis on the role of DNA topoisomerase IIA M Deffie, J P McPherson, R S Gupta, et al.Cancer Treatment Reports|July 1, 1985
Cooperative trial of immunotherapy for nasopharyngeal carcinoma with transfer factor from donors with Epstein-Barr virus antibody activityG J Goldenberg, L J Brandes, W H Lau, et al.Pageof 5